Rituximab in Treating Patients With Multiple Myeloma

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

November 30, 1998

Study Completion Date

April 30, 2004

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL

rituximab

DRUG

melphalan

DRUG

prednisone

Trial Locations (1)

Cleveland Clinic Taussig Cancer Center, Cleveland

All Listed Sponsors

lead

The Cleveland Clinic

OTHER

NCT00003554 - Rituximab in Treating Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter